At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 54 enrolled
Drug / intervention
Ketamine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does a Ketamine Infusion Decrease Post Operative Narcotic Consumption After Gastric Bypass Surgery?
In Brief
A Phase 4 clinical trial evaluating Ketamine, Narcotics, and 1 other intervention for Laparoscopic Gastric Bypass and 2 related conditions. Completed, enrolled 54 participants across 1 site.
Detailed Summary
This study will help to determine if investigators can minimize narcotic use in laparoscopic gastric bypass patients while maintaining adequate pain control. This will allow investigators to minimize the negative side effects of narcotics which is a goal in this population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaparoscopic Gastric Bypass, Obesity, Pain, Postoperative
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartFeb 2017
Primary CompletionDec 2018
TodayJul 2026
First PostedDec 23, 2016
Enrollment StartFeb 22, 2017
Primary CompletionDec 21, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 9.5 years ago
Interventions
Ketaminedrug
Anesthesia of only Ketamine
Narcoticsdrug
The narcotic group will receive no ketamine but rather a more standard anesthetic
pain scalebehavioral
0-10 pain scale. 0 = no pain and 10 = worst pain